PUNE, India, July 2, 2018 /PRNewswire/ --
According to a new market research report "Slide Stainer Market by Product (Reagent, Equipment (Automated, Manual)), Technology (Hematoxylin & Eosin, Immunohistochemistry, In Situ Hybridization, Microbiology, Special Stains), End User (Hospital, Pharmaceutical, Academic) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%. The major factors driving
(Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )
Browse 104 market data Tables and 30 Figures spread through 140 Pages and in-depth TOC on "Slide Stainer Market"
Early buyers will receive 10% customization on this report
By product, the reagents segment accounted for the largest share of the Slide Stainers Market in 2017
On the basis of product, the reagents segment accounted for the largest share of the global Slide Stainers Market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.
By technology, the hematoxylin & eosin (H&E) segment held the largest share in 2017
Based on technology, the Slide Stainers Market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the Slide Stainers Market. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.
Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=134046412
By end user, the hospitals and diagnostic centers segment held the largest share of the Slide Stainers Market in 2017
On the basis of end user, the Slide Stainers Market is segmented into hospitals and diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies and other end users (contract research organizations and forensics, food, & environmental laboratories). The hospitals and diagnostic centers segment accounted for the largest share in 2017. Factors such as the growing prevalence of diseases and huge patient inflow in hospitals and diagnostic centers are driving the growth of this end-user segment.
North America dominated the market in 2017
North America accounted for the largest share of the Slide Stainers Market in 2017, followed by Europe and Asia Pacific. The highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are the major factors responsible for the large share of the North American Slide Stainers Market.
The prominent players in the global Slide Stainer Market are Roche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).
Know more about the Slide Stainer Market:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Salgarkar MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: firstname.lastname@example.org
Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All